Mark T. Dertzbaugh

2.1k total citations · 1 hit paper
23 papers, 1.8k citations indexed

About

Mark T. Dertzbaugh is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Mark T. Dertzbaugh has authored 23 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Mark T. Dertzbaugh's work include Bacterial Genetics and Biotechnology (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Transgenic Plants and Applications (4 papers). Mark T. Dertzbaugh is often cited by papers focused on Bacterial Genetics and Biotechnology (5 papers), Glycosylation and Glycoproteins Research (4 papers) and Transgenic Plants and Applications (4 papers). Mark T. Dertzbaugh collaborates with scholars based in United States and Australia. Mark T. Dertzbaugh's co-authors include Jiří Městecký, John H. Eldridge, Masatomo Hirasawa, Hiroshi Kiyono, Jerry R. McGhee, Charles O. Elson, Francis L. Macrina, M. Louise M. Pitt, Bruce E. Ivins and Patricia Fellows and has published in prestigious journals such as The Journal of Immunology, Oncogene and Annals of the New York Academy of Sciences.

In The Last Decade

Mark T. Dertzbaugh

23 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The mucosal immune system: from fundamental concepts to vaccine development

1992 768 citations Jerry R. McGhee, Jiří Městecký et al. Vaccine profile →

Peers

Countries citing papers authored by Mark T. Dertzbaugh

Since Specialization

Citations

This map shows the geographic impact of Mark T. Dertzbaugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Dertzbaugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Dertzbaugh more than expected).

Fields of papers citing papers by Mark T. Dertzbaugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Dertzbaugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Dertzbaugh. The network helps show where Mark T. Dertzbaugh may publish in the future.

Co-authorship network of co-authors of Mark T. Dertzbaugh

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Dertzbaugh. A scholar is included among the top collaborators of Mark T. Dertzbaugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Dertzbaugh. Mark T. Dertzbaugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Monoclonal Antibodies to Ricin: In Vitro Inhibition of Toxicity and Utility as Diagnostic Reagents 2005 ·Hybridoma ·Mark T. Dertzbaugh, Cynthia A. Rossi, Brian M. Paddle, Martha L. Hale, (unknown), (unknown)	19
2	Pulmonary gene expression profiling of inhaled ricin 2003 ·Toxicon ·Luis L. P. daSilva, (unknown), Chad J. Roy, Mark Martinez, (unknown), M. Louise M. Pitt, Thomas J. Downey, Mark T. Dertzbaugh	36
3	In vitro correlate of immunity in a rabbit model of inhalational anthrax 2001 ·Vaccine ·M. Louise M. Pitt, Stephen F. Little, Bruce E. Ivins, Patricia Fellows, James F. Barth, John F. Hewetson, Paul Gibbs, Mark T. Dertzbaugh, Arthur M. Friedlander	232
4	Genetically Engineered Vaccines: An Overview 1998 ·Plasmid ·Mark T. Dertzbaugh	47
5	The affinity of cholera toxin for Ni2+ ion 1998 ·Protein Engineering Design and Selection ·Mark T. Dertzbaugh, (unknown)	31
6	Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice 1997 ·Vaccine ·Mary Kate Hart, William D. Pratt, (unknown), Ralph F. Tammariello, Mark T. Dertzbaugh	53
7	A Francisella tularensis DNA clone complements Escherichia coli defective for the production of Era, an essential Ras-like GTP-binding protein 1997 ·Gene ·Mohammed Zuber, Timothy A. Hoover, Mark T. Dertzbaugh, Donald L. Court	27
8	Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization 1997 ·European Journal of Immunology ·M. Tomasi, Mark T. Dertzbaugh, Thomas L. Hearn, Robert L. Hunter, Charles O. Elson	18
9	Chromosomal translocations deregulating c-myc are associated with normal immune responses 1997 ·Oncogene ·Viktor Roschke, E. P. Kopantzev, Mark T. Dertzbaugh, Stuart Rudikoff	30
10	Oral‐Antigen Delivery by way of a Multiple Emulsion System Enhances Oral Tolerancea 1996 ·Annals of the New York Academy of Sciences ·Charles O. Elson, M. Tomasi, Mark T. Dertzbaugh, (unknown), Robert L. Hunter, Casey T. Weaver	20
11	Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum 1996 ·Vaccine ·Mark T. Dertzbaugh	68
12	Analysis of the DnaK molecular chaperone system of Francisella tularensis 1995 ·Gene ·Mohammed Zuber, Timothy A. Hoover, Mark T. Dertzbaugh, Donald L. Court	20
13	Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. 1995 ·The Journal of Immunology ·Charles O. Elson, (unknown), Mark T. Dertzbaugh, (unknown), (unknown)	74
14	Comparative effectiveness of the cholera toxin B subunit and alkaline phosphatase as carriers for oral vaccines 1993 ·Infection and Immunity ·Mark T. Dertzbaugh, Charles O. Elson	68
15	Reduction in oral immunogenicity of cholera toxin B subunit by N-terminal peptide addition 1993 ·Infection and Immunity ·Mark T. Dertzbaugh, Charles O. Elson	49
16	The mucosal immune system: from fundamental concepts to vaccine development breakdown → 1992 ·Vaccine ·Jerry R. McGhee, Jiří Městecký, Mark T. Dertzbaugh, John H. Eldridge, Masatomo Hirasawa, Hiroshi Kiyono	768
17	Inhibition of Streptococcus mutans glucosyltransferase activity by antiserum to a subsequence peptide 1990 ·Infection and Immunity ·Mark T. Dertzbaugh, Francis L. Macrina	18
18	Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein 1990 ·Infection and Immunity ·Mark T. Dertzbaugh, Darrell L. Peterson, Francis L. Macrina	60
19	Plasmid vectors for constructing translational fusions to the B subunit of cholera toxin 1989 ·Gene ·Mark T. Dertzbaugh, Francis L. Macrina	26
20	An enzyme immunoassay for the detection of staphylococcal protein A in affinity-purified products 1985 ·Journal of Immunological Methods ·Mark T. Dertzbaugh, Michael C. Flickinger, William B. Lebherz	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact